These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 18199616

  • 1. Bombesin receptor antagonists may be preferable to agonists for tumor targeting.
    Cescato R, Maina T, Nock B, Nikolopoulou A, Charalambidis D, Piccand V, Reubi JC.
    J Nucl Med; 2008 Feb; 49(2):318-26. PubMed ID: 18199616
    [Abstract] [Full Text] [Related]

  • 2. Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugs.
    Maina T, Nock BA, Zhang H, Nikolopoulou A, Waser B, Reubi JC, Maecke HR.
    J Nucl Med; 2005 May; 46(5):823-30. PubMed ID: 15872357
    [Abstract] [Full Text] [Related]

  • 3. [99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging.
    Nock B, Nikolopoulou A, Chiotellis E, Loudos G, Maintas D, Reubi JC, Maina T.
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):247-58. PubMed ID: 12552343
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
    Richter S, Wuest M, Krieger SS, Rogers BE, Friebe M, Bergmann R, Wuest F.
    Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors.
    Okarvi SM, Al Jammaz I.
    Nucl Med Biol; 2010 Apr; 37(3):277-88. PubMed ID: 20346867
    [Abstract] [Full Text] [Related]

  • 6.
    Shan L.
    ; 2004 Apr. PubMed ID: 20641508
    [Abstract] [Full Text] [Related]

  • 7. New Gastrin Releasing Peptide Receptor-Directed [99mTc]Demobesin 1 Mimics: Synthesis and Comparative Evaluation.
    Nock BA, Charalambidis D, Sallegger W, Waser B, Mansi R, Nicolas GP, Ketani E, Nikolopoulou A, Fani M, Reubi JC, Maina T.
    J Med Chem; 2018 Apr 12; 61(7):3138-3150. PubMed ID: 29517903
    [Abstract] [Full Text] [Related]

  • 8.
    Chopra A.
    ; 2004 Apr 12. PubMed ID: 20681076
    [Abstract] [Full Text] [Related]

  • 9. [(99m)Tc]Demomedin C, a radioligand based on human gastrin releasing peptide(18-27): synthesis and preclinical evaluation in gastrin releasing peptide receptor-expressing models.
    Nock BA, Cescato R, Ketani E, Waser B, Reubi JC, Maina T.
    J Med Chem; 2012 Oct 11; 55(19):8364-74. PubMed ID: 22966957
    [Abstract] [Full Text] [Related]

  • 10. Potent bombesin-like peptides for GRP-receptor targeting of tumors with 99mTc: a preclinical study.
    Nock BA, Nikolopoulou A, Galanis A, Cordopatis P, Waser B, Reubi JC, Maina T.
    J Med Chem; 2005 Jan 13; 48(1):100-10. PubMed ID: 15634004
    [Abstract] [Full Text] [Related]

  • 11. New [99mTc]bombesin analogues with improved biodistribution for targeting gastrin releasing-peptide receptor-positive tumors.
    García Garayoa E, Schweinsberg C, Maes V, Rüegg D, Blanc A, Bläuenstein P, Tourwé DA, Beck-Sickinger AG, Schubiger PA.
    Q J Nucl Med Mol Imaging; 2007 Mar 13; 51(1):42-50. PubMed ID: 17372572
    [Abstract] [Full Text] [Related]

  • 12.
    Shan L.
    ; 2004 Mar 13. PubMed ID: 20641306
    [Abstract] [Full Text] [Related]

  • 13. 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer.
    Zhang X, Cai W, Cao F, Schreibmann E, Wu Y, Wu JC, Xing L, Chen X.
    J Nucl Med; 2006 Mar 13; 47(3):492-501. PubMed ID: 16513619
    [Abstract] [Full Text] [Related]

  • 14. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.
    Santos-Cuevas CL, Ferro-Flores G, Arteaga de Murphy C, Ramírez Fde M, Luna-Gutiérrez MA, Pedraza-López M, García-Becerra R, Ordaz-Rosado D.
    Int J Pharm; 2009 Jun 22; 375(1-2):75-83. PubMed ID: 19393305
    [Abstract] [Full Text] [Related]

  • 15. Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells.
    Hoffman TJ, Gali H, Smith CJ, Sieckman GL, Hayes DL, Owen NK, Volkert WA.
    J Nucl Med; 2003 May 22; 44(5):823-31. PubMed ID: 12732685
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and exploration of novel radiolabeled bombesin peptides for targeting receptor positive tumor.
    De K, Banerjee I, Sinha S, Ganguly S.
    Peptides; 2017 Mar 22; 89():17-34. PubMed ID: 28088445
    [Abstract] [Full Text] [Related]

  • 17. Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.
    Breeman WA, de Jong M, Erion JL, Bugaj JE, Srinivasan A, Bernard BF, Kwekkeboom DJ, Visser TJ, Krenning EP.
    J Nucl Med; 2002 Dec 22; 43(12):1650-6. PubMed ID: 12468515
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclides.
    Mansi R, Wang X, Forrer F, Kneifel S, Tamma ML, Waser B, Cescato R, Reubi JC, Maecke HR.
    Clin Cancer Res; 2009 Aug 15; 15(16):5240-9. PubMed ID: 19671861
    [Abstract] [Full Text] [Related]

  • 19. In vitro and in vivo application of radiolabeled gastrin-releasing peptide receptor ligands in breast cancer.
    Dalm SU, Martens JW, Sieuwerts AM, van Deurzen CH, Koelewijn SJ, de Blois E, Maina T, Nock BA, Brunel L, Fehrentz JA, Martinez J, de Jong M, Melis M.
    J Nucl Med; 2015 May 15; 56(5):752-7. PubMed ID: 25791989
    [Abstract] [Full Text] [Related]

  • 20. microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.
    Chen X, Park R, Hou Y, Tohme M, Shahinian AH, Bading JR, Conti PS.
    J Nucl Med; 2004 Aug 15; 45(8):1390-7. PubMed ID: 15299066
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.